Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.